Quel est le prix pour Lexaria Bioscience Corp. (LEXXW)

Le prix pour Lexaria Bioscience Corp. (LEXXW) est $0.0012

Quelle est la capitalisation boursière pour Lexaria Bioscience Corp. (LEXXW)

La capitalisation boursière pour Lexaria Bioscience Corp. (LEXXW) est $29.83K

Lexaria Bioscience Corp. (LEXXW) Prix et Capitalisation Boursière

Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation and licensing of its patented drug delivery system, DehydraTECH. This innovative technology functions by integrating fat-soluble compounds or active pharmaceutical ingredients (APIs) with particular long-chain fatty acids and specific carrier substances. The aim of this process is to significantly boost their entry into the bloodstream, consequently enhancing their effectiveness, enabling lower overall dosages, and supporting healthier methods of oral consumption. DehydraTECH can be utilized with a broad spectrum of active molecules, including fat-soluble vitamins, pain relievers, hormones, PDE5 inhibitors, antiviral agents, oral nicotine and its analogues, and various cannabinoids. The company is also investigating DehydraTECH's potential therapeutic applications for conditions such as high blood pressure, cardiovascular diseases, and diabetes. Its versatility renders it suitable for integration into diverse product categories, encompassing pharmaceuticals, nutraceuticals, over-the-counter remedies, and consumer packaged goods. Established in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.

Prix pour LEXXW	L’actif B	La capitalisation boursière de B	Résultats
$216,576 $29.83K	NVDA	$5.383T	+18,048,007,156.22%
$177,956 $29.83K	AAPL	$4.423T	+14,829,661,031.74%
$167,374 $29.83K	GOOG	$4.160T	+13,947,866,034.72%
$147,378 $29.83K	MSFT	$3.663T	+12,281,483,523.62%
$116,316 $29.83K	AMZN	$2.891T	+9,693,002,692.49%

Prix pour LEXXW

L’actif B

La capitalisation boursière de B

Résultats

$216,576 $29.83K